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a b s t r a c t
Background: Sporulation is a complex cell differentiation programme shared by many members of the
Firmicutes, the end result of which is a highly resistant, metabolically inert spore that can survive harsh
environmental insults. Clostridioides difficile spores are essential for transmission of disease and are also
required for recurrent infection. However, the molecular basis of sporulation is poorly understood,
despite parallels with the well-studied Bacillus subtilis system. The spore envelope consists of multiple
protective layers, one of which is a specialised layer of peptidoglycan, called the cortex, that is essential
for the resistant properties of the spore. We set out to identify the enzymes required for synthesis of
cortex peptidoglycan in C. difficile.
Methods: Bioinformatic analysis of the C. difficile genome to identify putative homologues of Bacillus
subtilis spoVD was combined with directed mutagenesis and microscopy to identify and characterise
cortex-specific PBP activity.
Results: Deletion of CDR20291_2544 (SpoVDCd) abrogated spore formation and this phenotype was
completely restored by complementation in cis. Analysis of SpoVDCd revealed a three domain structure,
consisting of dimerization, transpeptidase and PASTA domains, very similar to B. subtilis SpoVD.
Complementation with SpoVDCd domain mutants demonstrated that the PASTA domain was dispensable
for formation of morphologically normal spores. SpoVDCd was also seen to localise to the developing
spore by super-resolution confocal microscopy.
Conclusions: We have identified and characterised a cortex specific PBP in C. difficile. This is the first
characterisation of a cortex-specific PBP in C. difficile and begins the process of unravelling cortex
biogenesis in this important pathogen.
© 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
C. difficile is the most common cause of nosocomial antibiotic-
associated diarrhoea, with an estimated 453,000 infections and
29,300 deaths per year in the USA alone [1]. C. difficile infection
(CDI) requires prior disruption to the gut microbiota, most
commonly due to an administered antibiotic [2]. As current treat-
ments largely rely on antibiotic therapy, with further consequent
damage to the microbiota, recurrent disease is common and is
associated with worse patient prognosis [3]. In recent years there
have been dramatic changes in C. difficile epidemiology, in partic-
ular due to the emergence of the epidemic ribotype 027 lineage, a
previously rare ribotype that was responsible for a series of large
hospital outbreaks in North America in the early years of this
century before spreading worldwide [4].
The spore is an absolute requirement for transmission of disease
[5], since it allows the organism to transit the lethal aerobic envi-
ronment while also providing significant resistance to desiccation,
heat and common disinfectants [6]. As a result, the spores shed by
an infected individual can survive in the environment for an
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extended period of time. This environmental contamination is a
particular problem in hospital environments where large numbers
of susceptible individuals are housed in close proximity. The pro-
cess of sporulation is still relatively poorly understood, despite
significant advances in recent years [7]. We have previously used
high-density transposon mutagenesis and TraDIS to identify a
subset of C. difficile genes required for formation of mature heat-
resistance spores [8]. In total, transposon insertions in 798 genes
were found to significantly impact sporulation, many with no clear
homology to previously characterised proteins. Very few of these
798 genes have been studied in C. difficile but many have homo-
logues in the well-studied Bacillus subtilis sporulation pathway.
However, despite the clear parallels between sporulation in
B. subtilis and C. difficile, there are enough critical differences to
greatly reduce the value of assumptions based on homology [9e11].
The response regulator Spo0A is the master regulator of sporula-
tion, phosphorylation of which sets in motion a complex asym-
metric cell differentiation programme involving the sequential
activation of a series of dedicated sigma factors that are in turn
responsible for the expression of the individual regulons required
for correct spore morphogenesis [12]. The result is the complex
multi-layered spore structure that lends robustness to environ-
mental insult. The spore consists of a dehydrated core surrounded
by a membrane and peptidoglycan cell wall (primordial wall)
derived from the mother cell envelope. Around this is a thick
peptidoglycan cortex, synthesised during spore maturation, and a
secondmembrane, formed as a result of engulfment of the prespore
by the mother cell. The outer surface consists of multiple layers of
highly crosslinked proteins. The order and timing of synthesis of
each of these layers is critical and disruption to any of the steps
typically results in the formation of defective spores that lack full
resistance properties [9].
In B. subtilis the peptidoglycan of the primordial wall and cortex
differ in structure allowing differentiation by the cortex lytic hy-
drolases during germination [13]. The primordial cell wall consists
of typical alternating b-1/4-linked N-acetyl glucosamine and N-
acetyl muramic acid residues, crosslinked by 4e3 linked peptide
stems attached to the muramic acid moieties. In cortex peptido-
glycan, every second N-acetyl muramic acid is modified to mur-
amic-d-lactam, resulting in fewer stem peptides, fewer crosslinks
and a more flexible overall structure [14]. The class B penicillin-
binding protein (PBP) SpoVD is critical for synthesis of B. subtilis
cortex [15]. During sporulation SpoVD is expressed in the mother
cell where it interacts with the SEDS protein SpoVE to enable
localisation to the asymmetric division septum [16]. An N-terminal
transmembrane alpha helix anchors the protein in the membrane,
placing the majority of the protein in the inter-membrane space
where the cortex is ultimately synthesised [17]. SpoVD consists of a
PBP dimerization domain, followed by a transpeptidase domain
and a penicillin-binding protein and serine/threonine kinase
associated (PASTA) domain, the last of which is dispensable for
cortex formation [18].
C. difficile vegetative cell peptidoglycan is superficially similar to
that of B. subtilis, albeit with a preponderance of 3-3 cross-linking
as a result of L,D-transpeptidase activity [19]. The structure of the
C. difficile cortex peptidoglycan also differs, with only approxi-
mately half the abundance of muramic-d-lactam modifications and
significant GlcNAc N-deacetylation that is not seen at all in
B. subtilis [20,21]. Although the enzymes required for cortex syn-
thesis have yet to be characterised in detail, we have previously
shown that CDR20291_2544 is required for sporulation [8] and it
has been recently been confirmed that this enzyme is required for
sporulation and is the target of cephamycin antibiotics that inhibit
spore formation [22]. Here we set out to identify and characterise
the major C. difficile cortex PBP.
2. Methods
2.1. Bacterial strains and growth conditions
All bacterial strains, plasmids and oligonucleotides used in this
study are described in Table 1. E. coli strainswere routinely grown in
LB broth and on LB agar, while C. difficile strains were grown in TY
broth [23] and on brain heart infusion agar. Cultures were sup-
plemented with chloramphenicol (15 mg/ml), thiamphenicol
(15 mg/ml) or cycloserine (250 mg/ml) as appropriate.
2.2. Molecular biology methods
Routine molecular biology techniques were performed accord-
ing to the manufacturers protocols except where otherwise stated.
PCR using Phusion High-Fidelity DNA Polymerase, plasmid isola-
tion and purification of DNA fragments were performed using kits
and reagents supplied by Thermo Fisher Scientific according to the
manufacturer's instructions. Restriction digestion, ligation and
Gibson assembly were performed with enzymes supplied by New
England Biolabs. Competent E. coli were transformed using stan-
dard methods and plasmid DNA was transferred to C. difficile as
described previously [24]. C. difficile mutants were constructed by
homologous recombination as described previously [25,26]. Mu-
tants were confirmed by PCR and Southern blotting using the
Amersham ECL Direct Labelling and Detection System kit (GE) ac-
cording to the manufacturer's instructions. A 230 bp probe to the
region immediately upstream of spoVDCd was generated by PCD
using primer pair RF461/RF462.
2.3. Plasmid construction
pJAK032: pRPF150 was modified by inverse PCR using primer
pair NF1957/NF1958 to introduce an XhoI site between the Strep
Tag II and SecA2 coding sequences, yielding pJAK012. The Strep Tag
II coding sequence was then excised using SacI and XhoI and
replaced with a synthetic DNA fragment (IDTgBlock) consisting of a
codon-optimized CLIP gene, modified by PCR with primer pair
RF226/RF227 to add appropriate SacI and XhoI sites.
pYAA024: Homology arms upstream and downstream of
spoVDCd were amplified by PCR using oligonucleotide pairs RF68/
RF139 and RF69/RF187. The resulting PCR products were joined
together in a SOEing PCR reaction and cloned between the BamHI
and SacI sites in pMTL-YN4.
pYAA027: spoVDCd expression appears to be driven from a pro-
moter upstream of CDR20291_2545. In order to ensure comple-
mentation at wild type levels a fragment comprising 282 bp
upstream of CDR20291_2545, CDR20291_2545 itself and spoVDCd
was amplified by PCR using primer pair RF324/RF325 and cloned
between BamHI and SacI sites in pMTL-YN2C.
pYAA031: secA2 in pJAK032 was replaced by spoVDCd. spoVDCd
was amplified by PCR using primer pair RF374/RF375, digestedwith
BamHI and XhoI and ligated to pJAK032 backbone cut with the
same enzymes.
pYAA047: 1200 bp upstream of spoVDCd, the SNAP tag gene from
pFT46 and the first 1200 bp of spoVDCdwere amplified by PCR using
primer pairs, RF528/RF529, RF530/RF531 and RF532/RF533
respectively. pMTL-SC7215 was linearized by PCR using primer pair
RF20/RF311. The four DNA fragments were then joined in a Gibson
assembly reaction.
pYAA048-050: The coding sequence of the SpoVDCd PBP
dimerization domain (pYAA048; primers RF582/RF583), PASTA
domain (pYAA049; primers RF584/RF585), or transpeptidase
domain (pYAA050; primers RF586/RF587) were deleted by modi-
fication of pYAA031 by inverse PCR and subsequent
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Table 1
Strains, plasmids and oligonucleotides used in this study.
Strain Characteristics Source
R20291 C. difficile ribotype 027 strain isolated during an outbreak at Stoke Mandeville hospital, UK in 2006. [34]
R20291DpyrE An R20291 pyrE deletion mutant. [26]
R20291DspoVD R20291 with the entire spoVD gene, except the first and last three codons, deleted. This study
R20291DspoVD
pyrE::spoVD
R20291DspoVD complemented by simultaneous restoration of the wild type pyrE gene and insertion




R20291 with the native spoVD locus modified by homologous recombination to add the coding
sequence of SNAP to the 50 end of spoVD.
This study
CA434 E. coli conjugative donor. HB101 carrying R702. [35]
NEB5a fhuA2 D(argF-lacZ)U169 phoA glnV44 F80D (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17. New England Biolabs
Plasmid Characteristics Source
pMTL960 E. coli-C. difficile shuttle vector. Nigel Minton
pRPF150 Pcwp2-Strep-tag II-secA2 cassette cloned between KpnI and BamHI sites in pMTL960. [36]
pJAK012 pRPF150 modified to introduce an XhoI site between Strep-tag II encoding sequence and the secA2
gene.
This study
pJAK032 Strep Tag II coding sequence in pJAK012 replaced with a codon-optimized CLIP gene. This study
pFT46 Plasmid containing a C. difficile codon-optimized copy of the SNAP gene under the control of a
tetracycline inducible promoter.
[37]
pMTL-YN4 Allele exchange vector for pyrE-based selection. [26]
pMTL-YN2C pyrE restoration vector allowing simultaneous insertion of cargo DNA between pyrE and
R20291_0189.
[26]
pMTL-SC7215 Allele exchange vector for codA-based selection. [25]
pYAA024 spoVD deletion: 1200 bp homology arms representing the sequence upstream and downstream of
R20291_2544 (spoVD) cloned into pMTL-YN4. Designed to delete all but the first and last 9 bp of
spoVD.
This study
pYAA027 SpoVD complementation: spoVD and its native promoter cloned into pMTLYN2C. This study
pYAA031 Constitutive CLIP-SpoVD: spoVD cloned between XhoI and BamHI sites in pJAK032. This study
pYAA047 SNAP-SpoVD: 1200 bp upstream of spoVDwas fused to the coding sequence of SNAP and the first 1200
bp of spoVD and the subsequent recombination cassette cloned into pMTL-SC7215.
This study
pYAA048 SpoVD(DDimerization): pYAA031 modified by deletion of the sequence encoding the SpoVD PBP
dimerization domain.
This study
pYAA049 SpoVD(DPASTA): pYAA031 modified by deletion of the sequence encoding the SpoVD PASTA domain. This study
pYAA050 SpoVD(DTranspeptidase): pYAA031 modified by deletion of the sequence encoding the SpoVD
transpeptidase domain.
This study
pYAA051 SpoVD(DDimer & PASTA): pYAA031 modified by deletion of the sequence encoding the SpoVD PBP
dimerization and PASTA domains.
This study
pYAA052 His-SpoVD: spoVD cloned into pET-28a between NcoI and XhoI sites. This study
Oligonucleotide Sequence Use
NF1957 GAGTCAGTTATAGATTCGATACTTGAC To introduce an XhoI site into pRPF150 by
inverse PCR with NF1958
NF1958 GAGTTTTTCAAATTGTGGATGACTCCAC To introduce an XhoI site into pRPF150 by
inverse PCR with NF1957
RF20 AAACTCCTTTTTGATAATCTCATGACC To linearize pMTL-SC7215 with RF311
RF139a GTCAGAGCTCGTTCTTTATTTAGATTAAATAAAGTCAATG To clone spoVD into pMTL-YN4 with RF187
RF187a GTCAGGATCCCTTAGGAATCAGAGAGTAGATAG To clone spoVD into pMTL-YN4 with RF139
RF226 GATCGAGCTCGGAGGAACTACTATGGATAAAGATTGTGAAATGAAAAG To add a 50 SacI site onto a codon optimized clip
gene fragment
RF227 GATCCTCGAGAGCAGCTGCTCCTAATCCTGGTTTTCCTAATC To add 3xAla codons and a 30 XhoI site onto a
codon optimized clip gene fragment
RF311 TAGGGTAACAAAAAACACCG To linearize pMTL-SC7215 with RF20
RF323a GTCAGGATCCGTTTATGGGTATATGTTAATTATCTGTTAC To clone R20291_2545 and spoVD into pMTL-
YN2C with RF324
RF324a GTCAGAGCTCCTTAGGAATCAGAGAGTAGATAG To clone R20291_2545 and spoVD into pMTL-
YN2C with RF323
RF374a GATCCTCGAGAGAAAAGTAAAGAGGATAAGTAAGAAAAGG To clone spoVD into pJAK032 with RF375
RF375a GTCAGGATCCTTAGTTTTCAAAATATAGGGTTATACTTGAG To clone spoVD into pJAK032 with RF374
RF461 CTCAAATCTATTCCCCCTAGTTATCC To amplify spoVD promoter probe with RF462 for
Southern blotting
RF462 GAATCTATGTGGTTATTCAAAAATCTCG To amplify spoVD promoter probe with RF462 for
Southern blotting
RF528 aaatacggtgttttttgttaccctaagtttAAGCTAGAATAGATGGACC To amplify 1200 bp homology arm upstream of
spoVD
RF529 acaatctttatccatATCTATTCCCCCTAGTTATCC To amplify 1200 bp homology arm upstream of
spoVD
RF530 ctagggggaatagatATGGATAAAGATTGTGAAATGAAGAGAACCAC To amplify SNAP
RF531 cctctttacttttctAGCAGCTGCCCCAAGTCC To amplify SNAP
RF532 cttggggcagctgctAGAAAAGTAAAGAGGATAAGTAAGAAAAG To amplify first 1200 bp of spoVD
RF533 tttggtcatgagattatcaaaaaggagtttTAAATCTATACCTGTCTTATCCATAAG To amplify first 1200 bp of spoVD
RF582 TATATCTCTTGTTTGTTGTTCTAGTGCTTTTG To delete the coding sequence of the SpoVD PBP
Dimerization domain with RF583
RF583 GCAAAAAAGGTTACTGCAATAGCTATG To delete the coding sequence of the SpoVD PBP
Dimerization domain with RF582
(continued on next page)
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recircularization by ligation.
pYAA051: pYAA048 was further modified to delete the coding
sequence of the PASTA domain by inverse PCR with primers RF584/
RF585.
2.4. Sporulation efficiency analysis
Overnight cultures of C. difficile R20291 were diluted in BHI
broth to an OD600nm of 0.01, incubated for 8 h at 37
C, diluted to an
OD600nm of 0.0001 and finally incubated overnight. This allowed us
to obtain cultures in stationary phase with no detectable spores
(T ¼ 0). This culture was then incubated for 5 days with vegetative
cells and spores enumerated daily. For total viable counts, 10-fold
serial dilutions were spotted onto BHIS agar supplemented with
0.1% sodium taurocholate. For total spore counts, the same process
was carried out following a 30 min incubation at 65 C. Colonies
were counted after 24 h incubation at 37 C and the assay was
completed in biological triplicates. Formation of phase bright
spores was also followed by phase-contrast microscopy at each
time point. Samples fixed in 3.7% paraformaldehyde were imaged
using a Nikon Eclipse Ti microscope and analysed using Fiji [27].
2.5. Microscopy
Bacterial samples were harvested by centrifugation, washed
once with PBS and fixed in 4% paraformaldehyde. For phase-
contrast microscopy, samples were mounted in 80% glycerol and
imaged using a Nikon Ti Eclipse inverted microscope. Samples for
transmission electron microscopy were fixed as above before
additional fixation in 3% glutaraldehyde, 0.1 M cacodylate buffer.
Fixed samples were then treated with 1% OsO4, dehydrated in
ethanol and embedded in araldite resin. Embedded samples were
sectioned at 85 nm on a Leica UC6 ultramicrotome, transferred onto
coated copper grids, further stained with uranyl acetate and lead
citrate and visualised using a FEI Tecnai BioTWIN TEM at 80 kV
fitted with a Gatan MS600CW camera.
For fluorescence confocal microscopy, bacteriawere grown in TY
broth containing 500 nM HADA [28], labelled with 250 nM SNAP-
Cell TMR-Star (New England Biolabs) and grown under anaerobic
conditions for a further 60 min. Following labelling, cells were
harvested at 8000g for 2 min at 4 C and washed twice in 1 ml ice
cold PBS. Cells were resuspended in PBS and fixed in a 4% para-
formaldehyde at room temperature for 30 min with agitation. Cells
were washed three times in 1 ml ice cold PBS, immobilized by
drying to a coverslip and mounted in SlowFade Diamond (Thermo
Fisher Scientific). Images were captured using a Zeiss AiryScan
confocal microscope.
3. Results
3.1. C. difficile produces a SpoVD homologue that is required for
sporulation
The C. difficile R20291 genome encodes 10 putative penicillin-
binding proteins (PBPs) (Table 2) and one predicted monofunc-
tional transglycosylase (CDR20291_2283). In our previous trans-
poson mutagenesis study only two of these, CDR20291_0712 and
0985, were identified as essential for growth in vitro [8]. However,
five of the PBPs were required for formation of heat-resistant
spores, including two with homology to the B. subtilis cortex spe-
cific PBP SpoVD, CDR20291_1067 and 2544. Of these only
CDR20291_2544 has the C terminal PASTA domain that is charac-
teristic of the B. subtilis sporulation-specific PBPs [18].
CDR20291_2544 (SpoVDCd) shares 40.1% amino acid identity with
B. subtilis SpoVD and has the same predicted overall organisation,
with an N terminal predicted transmembrane helix, followed by a
PBP dimerization domain (PF03717), a transpeptidase domain
(PF00905) and the C terminal PASTA domain (PF03793). spoVD is
located immediately downstream of CDR20291_2545 (Fig. 2A),
encoding a protein with weak homology to B. subtilis FtsL (18.8%
amino acid identity). Despite the weak similarity, the C. difficile and
B. subtilis proteins are very similar in size (115 and 117 amino acids
respectively), have a similar PI (9.57 and 9.63 respectively) and both
have a high proportion of lysine residues (22.6% and 14.5%
Table 1 (continued )
Strain Characteristics Source
RF584 GGTTTAACTCCCAAATATTTTAAAGAGTCATTC To delete the coding sequence of the SpoVD
PASTA domain with RF585
RF585 TAAGGATCCACTAGTAACGGCC To delete the coding sequence of the SpoVD
PASTA domain with RF584
RF586 AGTATATAAAGAAGAAGAAAAAGCTGAGTATG To delete the coding sequence of the SpoVD
Transpeptidase domain with RF587
RF587 ATTATTTAACTCATAAGCTTTCTGTACTGC To delete the coding sequence of the SpoVD
Transpeptidase domain with RF586
a Restriction endonuclease sites are underlined.
Table 2
Putative C. difficile PBPs.
C. difficile R20291 gene designation Best B. subtilis strain 168 hit Amino acid identity Essential in vitro?
0712 PonA 27.3% Yes
2544 SpoVD 40.1% No but required for sporulation
1067 SpoVD 27.9% (PbpB 26.6%) No but required for sporulation
1131 DacF 43.8% No but required for sporulation
1318 PbpX 21.3% (PbpE 20.4%) No
2048 DacF 31.5% No but required for sporulation
0441 DacF 30.3% No
0985 PbpA 21.2% Yes
3056 PbpX 20.1% No but required for sporulation
2390 DacB 27.5% No
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respectively). CDR20291_2545 and spoVDCd appear to be in an
operon, with the promoter upstream of CDR20291_2545. In our
earlier TraDIS screen, CDR20291_2545 was also found to be
required for sporulation, although this may have been due to polar
effects on spoVDCd.
To confirm a role in sporulation, we constructed a clean spoVDCd
deletion by homologous recombination and then complemented
this mutant by integrating the CDR20291_2545-spoVDCd cassette
under the control of the native promoter into the chromosome
between the pyrE and R20291_0189 genes (referred to here as
R20291DspoVD pyrE:spoVD; Fig. 1A and B). We then analysed the
ability of each strain to form heat-resistant spores. In our assay, a
stationary phase culture of wild type R20291 gradually accumu-
lated spores, accounting for 81% of the viable counts after 3 days
(Fig. 1C). In the same assay R20291DspoVD formed no detectable
spores, even after 5 days of incubation (Fig. 1D). Complementation
completely restored sporulation to wild type levels (Fig. 1E). Ex-
amination by phase-contrast microscopy confirmed the presence of
abundant mature phase bright spores in 5 day old cultures of wild
type R20291 and the complemented strain R20291DspoVD pyrE:s-
poVD (Fig. 2A). In contrast no phase bright objects were observed in
cultures of R20291DspoVD. When visualised at higher magnifica-
tion using TEM of thin sections, no morphologically normal spores
were observed in cultures of R20291DspoVD (Fig. 2B). Membrane-
bound prespores were present, but these structures were irreg-
ular in shape and crucially lacked the cortex and protein coat layers
seen in R20291 and the complemented strain developing spores.
SpoVDCd is predicted to consist of 3 domains: a PBP dimerization
domain, a transpeptidase domain and a PASTA domain (Fig. 3A). To
identify which of these were required for viable spore formation,
CLIP-spoVDCd was placed under the control of a constitutive pro-
moter (Pcwp2) in a C. difficile expression vector and a panel of mu-
tants, lacking one or more of these domains, were constructed
(Table 1). These plasmids were all transferred into R20291DspoVD
and the ability of the expressed CLIP-SpoVDCd variant to restore
sporulation was evaluated. Only proteins including both the
dimerization and transpeptidase domains (SpoVD(DPASTA) or full-
length SpoVD) restored normal sporulation (Fig. 3B), the PASTA
domain was dispensable as observed previously in B. subtilis [18].
This observation was supported by TEM examination, with
morphologically normal spores only observed when the full-length
or SpoVD(DPASTA) proteins were expressed (not shown).
B. subtilis SpoVD, and the wider family of class B PBPs, share a
conserved active site consisting of 3 non-contiguous motifs that are
brought into close proximity in the folded enzyme, SxxK, SxN and
KTG [29]. The first of these motifs contains the essential serine
Fig. 1. Sporulation requires SpoVDCd. A. Genomic organisation of the native spoVDCd locus (WT), following deletion of the spoVDCd gene (D) and following complementation by
insertion of R20291_2545 and spoVDCd between the pyrE and R20291_0189 genes (Comp). The locations of XmnI (X) and BsrGI (B) sites are indicated, as is the annealing site of the
Southern blot probe. The length of the diagnostic restriction product containing the probe sequence is also shown below each locus diagram. B. Southern blot analysis of a spoVDCd
mutant (R20291DspoVD), the wild type parental strain (R20291) and complemented strain (R20291DspoVD pyrE:spoVD). A DNA ladder is shown on the left hand side. The predicted
fragment sizes and annealing site of the probe are shown in panel A. C.-E. Sporulation efficiencies of the wild type (C.), spoVDCd mutant (D.) and complemented strains (E.).
Stationary phase cultures were incubated anaerobically for 5 days with samples taken daily to enumerate total colony forming units (CFUs) and spores, following heat treatment to
kill vegetative cells. Experiments were performed in duplicate on biological triplicates with mean and standard deviation shown. The dotted horizontal line indicates the limit of
detection of the experiment.
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nucleophile. SpoVDCd has all three motifs, with Ser311 as the pre-
dicted nucleophile. SpoVDCd S311A supplied in trans was also
incapable of complementing the sporulation defect observed in a
spoVDCd deletion mutant (Fig. 3B), confirming a role for this residue
in cortex synthesis.
3.2. Subcellular localisation of SpoVDCd
To visualise the cellular localisation of SpoVDCd, we fused the
coding sequence for SNAP to the 50 end of the spoVDCd gene and
transferred this to the C. difficile genome in the native locus and
under the control of the native promoter. SNAP was then labelled
with the fluorescent reagent TMR-Start, while newly synthesised
peptidoglycan was labelled with the fluorescent D-amino acid
HADA [28]. Using Airyscan confocal microscopy we observed weak
punctate fluorescence around the periphery of the cell, localizing to
the asymmetric division septum once the cell had committed to
sporulation (Fig. 4A). Fluorescence then tracked the asymmetric
membrane through engulfment (Fig. 4B and C), eventually sur-
rounding the prespore (Fig. 4D). Localisation of SNAP-SpoVDCd
clearly preceded significant cortex synthesis as we visualised
localisation around the spore without concomitant HADA accu-
mulation (Fig. 4D). Following further spore maturation (Fig. 4E),
accumulation of new HADA-labelled peptidoglycan co-localized
with SNAP-SpoVDCd.
4. Discussion
C. difficile is the most common cause of hospital acquired
infection in the USA and Europe [30,31]. The formation of a robust
spore form is crucial for transmission of infection between patients
and for persistence and relapse following treatment [5]. However,
despite their importance in C. difficile pathogenesis, we still know
surprisingly little about the underlying molecular mechanisms of
sporulation and germination, in part due to a lack of effective ge-
netic tools until recently [32]. Much can be learned from the par-
allels with the well-studied but distantly related species B. subtilis,
however there are significant differences in the sporulation
Fig. 2. Microscopic analysis of sporulation. Phase-contrast light microscopy (A.) and negative stained TEM (B.) of the wild type parental strain (R20291), spoVDCd mutant
(R20291DspoVD) and complemented strain (R20291DspoVD pyrE:spoVD). A. Cultures were imaged at day 5 of the sporulation assays shown in Fig. 1. Spores are visible as ovoid phase
bright objects i, while vegetative cells are phase dark bacilli. B. TEM imaging of developing spores clearly shows normal spore development in R20291 and R20291DspoVD pyr-
E:spoVD; the densely stained core surrounded by a thick, largely unstained cortex layer. Cultures of R20291DspoVD contained no morphologically normal developing spores,
although fully engulfed prespores without a cortex (example shown) were common.
Fig. 3. The contribution of SpoVDCd domains to sporulation. A. The domain organi-
sation of SpoVDCd showing Pfam predictions [33]. B. Sporulation efficiency of R20291,
R20291DspoVD and R20291DspoVD complemented in trans using plasmids expressing
a series of mutant CLIP-SpoVDs under the control of a constitutive promoter: full-
length CLIP-SpoVDCd (spoVD); CLIP-SpoVDCd lacking the PBP dimerization domain
(DDimerization), PASTA domain (DPASTA), transpeptidase domain (DTranspeptidase)
or both PBP dimerization and PASTA domains (DDimer & PASTA); CLIP-SpoVDCd
lacking the active site nucleophile serine (S311A). Shown is the sporulation efficiency
after 5 days in broth culture, expressed as number of spores as a percentage of total
viable CFUs. Experiments were conducted in duplicate on biological triplicates and
mean and standard deviations are shown.
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pathways between the Bacillales and Clostridiales and even ho-
mologous proteins can play subtly different roles [9e11]. Here we
have identified and characterised a C. difficile homologue of the
B. subtilis spore cortex PBP SpoVD. We have confirmed that this
protein is required for sporulation in C. difficile.
Bioinformatic analysis of the C. difficile genome identified 10
genes encoding proteins with significant homology to charac-
terised B. subtilis PBPs. In a previous transposonmutagenesis screen
we determined that only two of these are essential for growth
in vitro, but five were required for formation of heat-resistant
spores [8]. One of these (R20291_2544) encodes a protein sharing
40.1% amino acid identity with B. subtilis SpoVD. Despite this
relatively weak homology, the two proteins share a similar overall
domain organisation and are encoded in a similar genomic context.
To determine if this protein played a role in C. difficile sporulation
we constructed a clean deletion mutant that we found to be inca-
pable of producing viable spores. Microscopic examination of this
mutant allowed us to visualise fully engulfed prespores but these
structures lacked any obvious cortex. This sporulation defect was
fully complemented by integration of spoVDCd (and the upstream
R20291_2545 and native promoter) in a distal chromosomal locus.
These observations clearly demonstrated that SpoVDCd plays a
crucial role in C. difficile sporulation and is required for the syn-
thesis of cortex peptidoglycan. We then demonstrated that the
sporulation defect in a spoVDCd mutant could be complemented by
expression in trans of amutant CLIP-SpoVDCd lacking the C terminal
PASTA domain but that mutation of the PBP dimerization or
transpeptidase domains resulted in a non-functional SpoVDCd. This
is in full agreement with previous B. subtilis studies that showed
that the PASTA domainwas dispensable for cortex synthesis [18]. By
comparison with the B. subtilis sequence we were also able to pu-
tatively identify the active site nucleophile serine as S311 and
confirmed this role by mutation to alanine, resulting in a non-
functional SpoVDCd.
It has been shown previously that B subtilis SpoVD localises to
the asymmetric septum upon initiation of sporulation and ulti-
mately to the developing spore following engulfment [17]. To
visualise this process in C. difficilewe generated a strain expressing
SNAP-SpoVDCd under the control of the native promoter. Super-
resolution fluorescence microscopy imaging of this strain showed
clear localisation of SNAP-SpoVDCd to the asymmetric septum and
to the developing spore. Intriguingly we also observed weak
punctate fluorescence staining around the periphery of the mother
cell. This could be indicative of mislocalisation as a result of the N
terminal SNAP fusion or could suggest a broader role for SpoVDCd in
vegetative cell peptidoglycan synthesis. To test this latter possibil-
ity, we examined the peptidoglycan composition of wild type and
spoVDCd mutant cells but observed no obvious differences. How-
ever, given the enormous potential for redundancy with 10 enco-
ded PBPs it is possible that small differences could be missed in this
analysis.
Sporulation of C. difficile represents one of the most pressing
clinical challenges in tackling recurrent disease in individual pa-
tients as well as preventing outbreaks in nosocomial settings.
However, this cell differentiation pathway also represents a
promising target for the development of C. difficile-specific thera-
peutics. Indeed it has been shown that inhibition of sporulation
with the SpoVD-targeting cephamycin cefotetan prevents relapse
in a mouse model of CDI [22]. In order to exploit this potential fully
however, wemust first develop a deeper understanding of both the
complex regulatory processes that underpin sporulation as well as
the function of the effector proteins that direct differentiation. Here
we have identified and characterised a PBP that is absolutely
required for production of viable spores and that we believe is a
promising target for future therapeutics aimed at preventing
recurrent disease and transmission.
Fig. 4. Subcellular localisation of SpoVDCd. R20291 SNAP-spoVDCd was grown for 24 h in TY broth containing the fluorescent D-amino acid HADA (500 nM) to label de novo syn-
thesised peptidoglycan. The bacteria were then further stained with SNAP-Cell TMR-Star (250 nM) to label SNAP-SpoVDCd, fixed, mounted in SlowFade Diamond mountant and
imaged using a Zeiss AiryScan confocal microscope. Shown are representative cells demonstrating the sequential stages of sporulation: asymmetric septum placement, early,
intermediate and complete prespore engulfment respectively, and spore maturation.
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